ALLO — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

15.06

Margin Of Safety %

Put/Call OI Ratio

0.16

EPS Next Q Diff

-0.02

EPS Last/This Y

0.13

EPS This/Next Y

-0.01

Price

2.62

Target Price

7.36

Analyst Recom

1.54

Performance Q

94.07

Upside

-531.7%

Beta

0.59

Ticker: ALLO

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	ALLO	2.51	0.17	0.01	11759
2026-03-10	ALLO	2.7	0.17	1.40	11977
2026-03-11	ALLO	2.62	0.19	0.02	12331
2026-03-12	ALLO	2.47	0.19	0.45	12363
2026-03-13	ALLO	2.47	0.19	0.45	12363
2026-03-17	ALLO	2.28	0.18	0.02	15427
2026-03-18	ALLO	2.15	0.17	0.18	16501
2026-03-19	ALLO	2.22	0.17	0.29	17657
2026-03-20	ALLO	2.08	0.17	0.23	17970
2026-03-23	ALLO	2.43	0.18	0.13	10109
2026-03-24	ALLO	2.21	0.17	0.71	11034
2026-03-25	ALLO	2.33	0.17	0.20	11221
2026-03-26	ALLO	2.42	0.17	0.07	11297
2026-03-27	ALLO	2.27	0.16	0.03	12193
2026-03-30	ALLO	2.21	0.16	0.31	12313
2026-03-31	ALLO	2.43	0.16	0.02	12476
2026-04-01	ALLO	2.56	0.16	0.01	12667
2026-04-02	ALLO	2.48	0.16	0.06	12961
2026-04-06	ALLO	2.61	0.16	0.14	13089
2026-04-07	ALLO	2.63	0.16	0.31	13462
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	ALLO	2.50	21.7	-	-0.94
2026-03-10	ALLO	2.71	21.7	-	-0.94
2026-03-11	ALLO	2.63	21.7	-	-0.94
2026-03-12	ALLO	2.47	21.7	-	-0.94
2026-03-13	ALLO	2.40	21.7	-	-0.94
2026-03-17	ALLO	2.27	21.7	-	-0.81
2026-03-18	ALLO	2.15	21.7	-	-0.75
2026-03-19	ALLO	2.23	21.7	-	-0.75
2026-03-20	ALLO	2.07	35.7	-	-0.71
2026-03-23	ALLO	2.43	35.7	-	-0.71
2026-03-24	ALLO	2.21	35.7	-	-0.74
2026-03-25	ALLO	2.33	35.7	-	-0.74
2026-03-26	ALLO	2.42	35.7	-	-0.74
2026-03-27	ALLO	2.27	35.7	-	-0.74
2026-03-30	ALLO	2.21	35.7	-	-0.74
2026-03-31	ALLO	2.44	35.7	-	-0.74
2026-04-01	ALLO	2.56	35.7	-	-0.74
2026-04-02	ALLO	2.48	35.7	-	-0.74
2026-04-06	ALLO	2.61	35.7	-	-0.74
2026-04-07	ALLO	2.62	35.7	-	-0.74
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-09	ALLO	-0.35	2.40	13.35
2026-03-10	ALLO	-0.35	2.40	13.35
2026-03-11	ALLO	-0.35	2.40	16.00
2026-03-12	ALLO	-0.35	2.40	16.00
2026-03-13	ALLO	-0.35	2.40	16.00
2026-03-17	ALLO	-0.32	2.25	14.75
2026-03-18	ALLO	-0.38	2.25	14.75
2026-03-19	ALLO	-0.38	2.25	14.75
2026-03-20	ALLO	-0.38	2.25	14.75
2026-03-23	ALLO	-0.38	1.34	14.75
2026-03-24	ALLO	-0.38	1.34	14.75
2026-03-25	ALLO	-0.38	1.34	15.06
2026-03-26	ALLO	-0.38	1.34	15.06
2026-03-27	ALLO	-0.38	1.34	15.06
2026-03-30	ALLO	-0.38	1.34	15.06
2026-03-31	ALLO	-0.38	1.34	15.06
2026-04-01	ALLO	-0.38	1.34	15.06
2026-04-02	ALLO	-0.39	1.34	15.06
2026-04-06	ALLO	-0.39	1.34	15.06
2026-04-07	ALLO	-0.39	1.34	15.06
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.17

Avg. EPS Est. Current Quarter

-0.18

Avg. EPS Est. Next Quarter

-0.18

Insider Transactions

-0.39

Institutional Transactions

1.34

Beta

0.59

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

92.7

Max Drawdown 5-Year %

-97.3

Target Price

7.36

P/E

Forward P/E

PEG

P/S

P/B

2.05

P/Free Cash Flow

EPS

-0.87

Average EPS Est. Cur. Y

-0.74

EPS Next Y. (Est.)

-0.75

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.65

Return on Equity vs Sector %

-92.7

Return on Equity vs Industry %

-76.2

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.15

EBIT Estimation

◆ ALLO Healthcare

$2.62

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

8/20

Pullback

6/25

Volume

9/15

Valuation

8/20

TP/AR

1/10

Options

8/10

RSI

58.4

Range 1M

82.2%

Sup Dist

5.3%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

8/25

Growth

14/30

Estimates

0/20

Inst/Vol

7/15

Options

8/10

EPS Yr

7.8%

EPS NY

1.5%

52W%

90.2%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +180.9% upside

Quality

2/30

Valuation

16/30

Growth

9/25

Stability

6/10

LT Trend

3/5

Upside

+180.9%

Quality

Allogene Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 150

Allogene Therapeutics, Inc. a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer and autoimmune diseases. It develops a pipeline of multiple allogeneic CAR T cell product candidates utilizing protein engineering, gene editing, gene insertion, and advanced proprietary T cell manufacturing technologies. The company is also developing cemacabtagene ansegedleucel (cema-cel), an engineered allogeneic CAR T cell product candidate that targets CD19 for the treatment of large B-cell lymphoma (LBCL). In addition, it develops ALLO-316, an engineered allogeneic CAR T cell product candidate that targets CD70 to treat renal cell carcinoma (RCC); and ALLO-329, an engineered allogeneic CAR T cell product candidate that targets both CD19 and CD70 for the treatment of autoimmune diseases (AID), such as systemic lupus erythematosus (SLE), idiopathic inflammatory myopathies (IIM), and systemic sclerosis (SSc). The company was incorporated in 2017 and is headquartered in South San Francisco, California.

ALLO

Latest News

—

Caricamento notizie per ALLO…

stock quote shares ALLO – Allogene Therapeutics, Inc. Stock Price stock today

news today ALLO – Allogene Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ALLO – Allogene Therapeutics, Inc. yahoo finance google finance

stock history ALLO – Allogene Therapeutics, Inc. invest stock market

stock prices ALLO premarket after hours

ticker ALLO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ALLO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y